CPHI 2024
October 08-10, 2024
Milan, Italy
https://www.cphi.com/europe/en/home.html
Subscribe to our press distribution list to receive the latest news about AMW.
October 08-10, 2024
Milan, Italy
https://www.cphi.com/europe/en/home.html
October 28-29, 2024
Boston, USA
https://poddconference.com
November 04-06, 2024
Stockholm, Sweden
https://informaconnect.com/bioeurope/
July 10-12, 2024
Bangkok, Thailand
https://www.cphi.com/sea/en/home.html
January 24-25, 2024 Paris, France https://www.pharmapackeurope.com/
read moreFebruary 08-09, 2024
London, UK
February 26-27, 2024 Lisbon, Portugal
read moreMarch 18-20, 2024
Barcelona, Spain
https://informaconnect.com/bioeurope-spring/
March 19-21, 2024
Boston, MA
https://wet-amd-drug-development.com/
June 03-06, 2024
San Diego, California
https://www.bio.org/events/bio-international-convention
Warngau, Germany, July 1, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the appointment of Prof. Miriam Breunig, Senior Academic Councillor at the University of Regensburg’s Department of Pharmaceutical Technology, and Prof. Karsten Mäder, Professor of Pharmaceutics at Martin Luther University Halle-Wittenberg, as members to AMW’s Scientific […]
read moreWarngau, June 3, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today reported financial results for the year ended December 31, 2023. AMW posted a 2023 consolidated record revenue of EUR 29.4 million and achieved operating profitability for the second consecutive year. In addition, the Company reported a partial […]
read moreWarngau, Germany, May 15, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that it has received the final report of the Notified Body Opinion (NBO) for its leuprorelin implant in pre-filled syringes. The NBO completes a diligent conformity review procedure by a notified body, in this case […]
read moreWarngau, Germany, April 11, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, was delighted to welcome today the President of the Bavarian State Parliament, Ilse Aigner, to its headquarters in Warngau near Munich, Germany. In her speech to AMW employees, Ms. Aigner acknowledged the Company’s innovative strength and emphasized […]
read moreWarngau, January 9, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that Dr. Joerg Serafimov has been appointed to the newly created role as Chief Business Officer (CBO), effective January 1, 2024. In this capacity, he is responsible for International Business and Licensing, Key Account Management, Business […]
read more